Beyond Just Peptide Antigens: The Complex World of Peptide-Based Cancer Vaccines.

Front Immunol · 2021 · PMC8279810 · PMID 34276688

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, encouragingly there is a clear trend towards a more personalised approach to patient neoepitope selection in the current pool of trials, with an increased focus on peptide-based cancer vaccines use in combination with other cancer treatment strategies ( 133 ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.